Rapamycin attenuates nigral and hippocampal alpha-synuclein accumulation in AAV-mediated alpha-synuclein overexpression model of Parkinson's disease

E. Cinar; G. Yalcin-Cakmakli; A. Ulusoy; E. Saka; B. Tel; B. Elibol

Rapamycin attenuates nigral and hippocampal alpha-synuclein accumulation in AAV-mediated alpha-synuclein overexpression model of Parkinson's disease

E. Cinar
, G. Yalcin-Cakmakli
, A. Ulusoy
, E. Saka
, B. Tel
, B. Elibol

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Pages (from-to)	S332-S332
Number of pages	1
Journal	Movement Disorders
Volume	36
Publication status	Published - Sept 2021

Cite this

@article{426fcdcb15ee44058bb90593b2f184e7,

title = "Rapamycin attenuates nigral and hippocampal alpha-synuclein accumulation in AAV-mediated alpha-synuclein overexpression model of Parkinson's disease",

author = "E. Cinar and G. Yalcin-Cakmakli and A. Ulusoy and E. Saka and B. Tel and B. Elibol",

year = "2021",

month = sep,

language = "English",

volume = "36",

pages = "S332--S332",

journal = "Movement Disorders",

issn = "0885-3185",

publisher = "John Wiley \& Sons Inc.",

}

TY - JOUR

T1 - Rapamycin attenuates nigral and hippocampal alpha-synuclein accumulation in AAV-mediated alpha-synuclein overexpression model of Parkinson's disease

AU - Cinar, E.

AU - Yalcin-Cakmakli, G.

AU - Ulusoy, A.

AU - Saka, E.

AU - Tel, B.

AU - Elibol, B.

PY - 2021/9

Y1 - 2021/9

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=performanshacettepe&SrcAuth=WosAPI&KeyUT=WOS:000694886400089&DestLinkType=FullRecord&DestApp=WOS_CPL

M3 - Meeting Abstract

SN - 0885-3185

VL - 36

SP - S332-S332

JO - Movement Disorders

JF - Movement Disorders

ER -

Rapamycin attenuates nigral and hippocampal alpha-synuclein accumulation in AAV-mediated alpha-synuclein overexpression model of Parkinson's disease

Other files and links

Cite this